The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of two new immunoassay interference blockers, K-Blockā¢, and Mouse-Free IgG.
Next-generation sequencing (NGS) will have a dramatic impact on healthcare in the next decade. But what are the real benefits of this trend? Learn more in this expert panel on accelerating precision medicine with low-cost whole-genome sequencing.
Download this Gene Expression and Regulation eBook to explore how next-generation sequencing (NGS) is accelerating high impact studies using bulk or single-cell RNA-Seq applications.